Kisspeptin-10 The Master Switch of the HPG Axis What it does: Kisspeptin-10 stimulates the hypothalamus to release gonadotropin-releasing hormone (GnRH), which triggers luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
Never discontinue or adjust GLP-1 medication without medical guidance, particularly if prescribed for diabetes management, as this may affect glycaemic control
GHRH analogs, including Mod GRF 1-29, bind directly to the GHRH receptor
Per KFF 2025, 43% of firms with 5,000-plus employees cover weight-loss GLP-1s (up from 28%), but only 30% of firms with 1,000 to 4,999 employees and 16% of firms with 200 to 999
Epidemiologic studies have consistently shown a mortality advantage among patients with hematocrits in the 30% to 36% range, and the NKF-DOQI Work Group on Anemia Management recommended a target hematocrit of 33% to 36% based on the expert panels' detailed literature review
Katherine Saunders, MD, co-founder of FlyteHealth and obesity medicine specialist at Weill Cornell Medicine in New York City, explains, The lack of coverage, high cost, and drug shortages are tremendous barriers to tirzepatide access right now, so many patients ask about compounded medications. However, that doesnt mean it is safe or even legal